Background Hepatitis B is one of the major infectious diseases of mankind, and up to now, there is no effective way to handle it. Recent clinical trials have shown the potential advantages of Kurorinone an extract of Chinese herb, in treament of chronic HBV infection.
Objectives Systermically review the safety and efficacy of Kurorinone in treatment of chronic HBV infection.
Search strategy With the searching terms including Kurorinone, its products’ name, hepatitis B and chronic carrier status, the trials registers of the Cochrane Hepato- Biliary Group, the Cochrane Complementary Medicine Field, and the central database of the Cochrane Library as well as MEDILINE, EMBASE and Chinese Biomedical CD Database were searched from their date of inception onward. 20 Chinese medical journals and relevant academic conference proceedings have been searched by hand. The reference lists of identified documents were checked as the complementary search.
Inclusion Criteria All RCTs that tested Kurorinone for chronic HBV infection were included in this review.
Method of the review According the demand of Cochrane systematic review, selection of trial for inclusion, assessment of methodological quality, data extraction and data syntheses would be conducted for each included trial.
Citation： SHI Rui,LI Jie,LIU Jianping. Sophorus for chronic hepatitis B virus infection: protocol of a systematic review. Chinese Journal of Evidence-Based Medicine, 2002, 02(1): 39-43. doi: Copy